Max Healthcare Share Price Target: Max Healthcare Institute Limited is a premier healthcare organization, providing services in hospitals, home care, and pathology across India. The company is a leader in offering a variety of specialized treatments, ranging from cancer and heart diseases to diabetes, joint replacements, and robotic surgeries. Headquartered in New Delhi, Max Healthcare operates in major metro and Tier-1 cities, with a significant focus on expanding its presence in new locations.
Max Healthcare Share Details
|
Metric |
Value |
|
Open |
995.10 |
|
High |
1,019.00 |
|
Low |
989.50 |
|
Market Cap |
97.74 K Cr |
|
P/E Ratio |
97.40 |
|
Dividend Yield |
0.15% |
|
52-week High |
1,227.95 |
|
52-week Low |
706.45 |
Max Healthcare Share Price Target 2025, 2026, 2027, 2028, 2029, 2030, 2040, 2050
Max Healthcare Share Price Target 2025 1800, 2026 2500, 2030 4310, 2040 8321, 2050 15800. Healthcare Institute Limited is an Indian for-profit private hospital chain headquartered in Delhi. As of 2024, Max Healthcare operates 19 hospitals with more than 4,000 beds, primarily in North India. Max Healthcare also operates the Max Lab pathology and Max@Home home medical services divisions.
- Stock price: MAXHEALTH (NSE) ₹1,004.45 -15.50 (-1.52%)
- Headquarters: New Delhi
- Founder: Analjit Singh
- Subsidiaries: Max Lab, Crosslay Remedies Limited ·
- Founded: 2001
- Number of employees: 15,000 (2023)
Max Healthcare Share Price Target 2025 to 2050
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
| 2025 | 800 | 1800 |
| 2026 | 1760 | 2500 |
| 2030 | 3700 | 4310 |
| 2040 | 7125 | 8321 |
| 2050 | 14200 | 15800 |
Category: Stock Market
Overview of Max Healthcare Ltd
Max Healthcare Ltd was established in 2000 and has grown to become one of the largest healthcare providers in India. The company offers diverse healthcare services, including treatments for critical ailments such as cancer, heart diseases, organ transplants, and more. With the healthcare sector growing rapidly, Max Healthcare’s strong track record and expansion strategies make it a prominent player in the field.
Max Healthcare Share Price Target for Tomorrow
At the moment, Max Healthcare’s stock is in a downward trend. The stock has formed an M-shaped pattern, indicating a further decline in the short term. Therefore, investors are advised to wait for a potential price correction before considering buying the stock.
| Day | Minimum Price (Rs) | Maximum Price (Rs) |
| Tomorrow | -70 | +60 |
Max Healthcare Share Price Target for 2025
By 2025, Max Healthcare is expected to continue its growth trajectory, benefiting from a robust healthcare sector and increasing demand for quality services. Given its focus on expanding healthcare services across India, the stock price for Max Healthcare could range from ₹800 to ₹1800. This period of growth is backed by its strategic investments in advanced healthcare technology, partnerships, and new market penetrations. The stock could potentially reach ₹1800, offering good upside potential for long-term investors. However, due to the current market dynamics, it is important to assess market trends before committing.
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
| 2025 | 800 | 1800 |
| Month | Minimum Price (Rs) | Maximum Price (Rs) |
| January | 880 | 1360 |
| February | 933 | 1400 |
| March | 980 | 1420 |
| April | 1050 | 1400 |
| May | 1100 | 1430 |
| June | 1180 | 1450 |
| July | 1230 | 1470 |
| August | 1230 | 1488 |
| September | 1470 | 1500 |
| October | 1480 | 1621 |
| November | 1590 | 1779 |
| December | 1760 | 1800 |
Max Healthcare Share Price Target for 2026
Looking ahead to 2026, Max Healthcare’s growth strategy is expected to intensify with greater reliance on technology and environmentally conscious operations. These efforts to modernize and increase efficiency make the stock a promising investment. Based on our analysis, the stock price target for 2026 is between ₹1760 to ₹2500, reflecting the company’s robust future potential. In 2026, the share price could rise to ₹2500, making it an attractive target for long-term investors looking to capitalize on the expanding healthcare market.
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
| 2026 | 1760 | 2500 |
| Month | Minimum Price (Rs) | Maximum Price (Rs) |
| January | 1760 | 1820 |
| February | 1788 | 1838 |
| March | 1810 | 1880 |
| April | 1850 | 1930 |
| May | 1880 | 1970 |
| June | 1955 | 2035 |
| July | 1980 | 2070 |
| August | 2044 | 2170 |
| September | 2140 | 2235 |
| October | 2210 | 2360 |
| November | 2280 | 2430 |
| December | 2408 | 2500 |
Max Healthcare Share Price Target for 2030
By 2030, Max Healthcare is expected to experience accelerated growth as it continues to acquire and partner with other businesses. With a focus on expanding its footprint in Tier-2 and Tier-3 cities, the company is likely to benefit from increased healthcare demand in these regions. Thus, the stock price target for 2030 is between ₹3700 to ₹4310. In 2030, the stock could potentially reach ₹4310, reflecting the company’s sustained growth due to strategic acquisitions and expansion into smaller cities.
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
| 2030 | 3700 | 4310 |
| Month | Minimum Price (Rs) | Maximum Price (Rs) |
| January | 3700 | 3788 |
| February | 3743 | 3860 |
| March | 3800 | 3910 |
| April | 3870 | 3960 |
| May | 3910 | 3988 |
| June | 3950 | 4020 |
| July | 3987 | 4054 |
| August | 4000 | 4090 |
| September | 4070 | 4150 |
| October | 4120 | 4180 |
| November | 4150 | 4260 |
| December | 4240 | 4310 |
Max Healthcare Share Price Target for 2040
The healthcare industry in India is expected to experience significant growth, particularly in Tier-2 and Tier-3 cities, where there is a high demand for medical services. Max Healthcare, with its expansion plans, is well-positioned to benefit from this shift. By 2040, the stock price could reach between ₹7125 and ₹8321, driven by its increased presence in underserved regions. Max Healthcare’s stock could see a substantial rise, with the potential to hit ₹8321 by 2040, driven by expansion into smaller cities and increased demand for healthcare services across India.
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
| 2040 | 7125 | 8321 |
| Month | Minimum Price (Rs) | Maximum Price (Rs) |
| January | 7125 | 7260 |
| February | 7190 | 7340 |
| March | 7267 | 7465 |
| April | 7370 | 7560 |
| May | 7460 | 7680 |
| June | 7569 | 7760 |
| July | 7680 | 7890 |
| August | 7756 | 7955 |
| September | 7869 | 8035 |
| October | 7960 | 8136 |
| November | 8056 | 8271 |
| December | 8233 | 8321 |
Max Healthcare Share Price Target for 2050
The healthcare sector in India is poised for robust growth, and Max Healthcare stands to gain from increased investments and demand for healthcare services. With rising incomes and government support, Max Healthcare’s stock is expected to surge over the next few decades. The 2050 price target for Max Healthcare is projected between ₹14200 and ₹15800. Max Healthcare’s stock is expected to hit ₹15800 by 2050, driven by the expansion of healthcare services and increasing access to quality care in India.
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
| 2050 | 14200 | 15800 |
| Month | Minimum Price (Rs) | Maximum Price (Rs) |
| January | 14200 | 14368 |
| February | 14330 | 14470 |
| March | 14400 | 14590 |
| April | 14510 | 14650 |
| May | 14589 | 14780 |
| June | 14620 | 14880 |
| July | 14780 | 14970 |
| August | 14890 | 14180 |
| September | 14120 | 14380 |
| October | 14270 | 14560 |
| November | 14470 | 14720 |
| December | 14680 | 15800 |
Should I Buy Max Healthcare Stock?
Max Healthcare offers strong growth potential, with its focus on expanding healthcare services, adopting technology, and entering new markets. However, the stock is currently experiencing a downward trend, suggesting that potential investors should wait for a correction before buying. Given its long-term growth prospects, Max Healthcare remains a strong contender for future investment.
Is Max Healthcare Stock Good to Buy?
Bull Case:
- Strong Long-Term Growth Potential: Max Healthcare has significant expansion plans, positioning itself for continued growth in the long term.
- Focus on Technology and Healthcare Improvements: The company is leveraging technology to enhance healthcare services, improving patient care and operational efficiency.
- Growing Healthcare Demand in India: As India’s healthcare sector continues to grow, Max Healthcare is well-placed to capitalize on increasing demand for healthcare services.
- Impressive Profit Growth: The company has delivered a remarkable 780% compound annual growth rate (CAGR) in profit over the past 5 years, demonstrating its strong financial performance.
- Experienced Management and Solid Strategy: Max Healthcare benefits from a seasoned management team with a clear and effective growth strategy.
Bear Case:
- Potential Overvaluation: With the stock trading at 12.7 times its book value, it may be overvalued, posing a risk to investors if the market corrects.
- Low Return on Equity (ROE): Max Healthcare has a relatively low ROE of 13.4% over the last 3 years, which may suggest inefficiencies in generating returns for shareholders.
- Declining Promoter Holding: The promoter holding has decreased by 37.2% in the past 3 years, which could indicate a lack of confidence from the company’s key stakeholders.
- Downward Stock Price Trend: The stock has been on a downward trend recently, which could suggest challenges in the market or investor sentiment.
- Manageable but Present Debt: While the company’s debt levels are manageable, they still pose a risk, especially in a volatile market environment.
- Intense Competition: The healthcare industry is highly competitive, with many players vying for market share, which could put pressure on Max Healthcare’s performance.
What is Max Healthcare famous for?
As a regional hub for complex medical procedures, Max Smart Super Speciality Hospital, Saket, is renowned for its expertise in neurovascular interventions, targeted cancer treatments, heart surgeries, orthopaedic surgeries, and a wide range of renal, bariatric, paediatric, obstetric, and gynaecological treatments.
Who is the owner of Max Healthcare?
Abhay Soi is the chairman and managing director of Max Healthcare. He is also a promoter of the company.
What is the salary in Max hospital?
The average Max Healthcare salary ranges from approximately ₹1,99,121 per year (estimate) for a Nurse to ₹67,50,000 per year (estimate) for a Head & Senior Vice President. Max Healthcare employees rate the overall compensation and benefits package 3.2/5 stars.
What is the salary of Max Healthcare CEO?
Max Healthcare Institute’s CEO is Abhay Soi, appointed in Jun 2020, has a tenure of 4.58 years. total yearly compensation is ₹247.33M, comprised of 79.7% salary and 20.3% bonuses, including company stock and options. directly owns 23.74% of the company’s shares, worth ₹236.07B.
DISCLAIMER
Browvopetshop.com is not liable for any claims, losses, or damages from the information provided. Content is general and not financial advice—consult a professional before investing. Personal financial factors are not considered, and potential conflicts of interest may exist. Trademarks, logos, and company names belong to their respective owners.